産生欠陥の治療: 胆酸合成の産生欠陥の例
Peter T Clayton1, Rohit Hirachan2, Elaine Murphy3
1Inborn Errors of Metabolism, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.
Journal of inherited metabolic disease
|August 23, 2025
まとめ
チェノドオキシコール酸 (CDCA) やホリック酸 (CA) のような胆汁代謝剤を用いた代替治療は,胆汁酸合成に影響する特定の先天性代謝異常,特に乳児における肝疾患や,脳突起性キサントマトーシス (CTX) などの疾患における神経学的症状を効果的に治療することができる.
科学分野:
- 生物化学
- 代謝障害
- 遺伝学
背景:
- 代謝の先天的な誤差は,しばしば代謝産物合成の欠陥から生じ,必要不可欠な化合物の不足による病気につながります.
- 3β-ヒドロキシ-Δ5-C27-ステロイド脱水素酶欠乏症のような胆酸合成の欠陥は,重度の乳児胆固醇性肝疾患を引き起こす可能性があります.
- 肝臓および/または神経疾患に伴う,脳胞性キサントマトーシス (CTX) とペロキシソーム生殖障害を含む他の代謝障害.
研究 の 目的:
- 代謝の先天性障害における"製品置換"戦略の治療的可能性を探求する.
- 特定の胆酸合成の欠陥および関連する肝臓疾患の治療におけるチェノドオキシコール酸 (CDCA) とホリック酸 (CA) の有効性を強調する.
- 胆汁酸とウルソデオキシコール酸が,様々な代謝疾患の神経学的および肝臓的症状の管理に用いられるかについて議論する.
主な方法:
- 胆酸合成とペロキシソーマ機能に影響を与える様々な代謝の先天性障害の臨床表現と治療結果のレビュー
- チェノドオキシコール酸 (CDCA) とコリック酸 (CA) の代替療法としての有効性の分析
- 3β-ヒドロキシ-Δ5-C27-ステロイド脱水素酶欠乏症,CTX,ペロキシソーマ障害などの特定の状態に対する治療アプローチの検討.
主要な成果:
- CDCAおよび/またはCAは,3β-ヒドロキシ-Δ5-C27-ステロイド脱水素酶の欠乏によって引き起こされる乳児胆固醇性肝疾患の治療に非常に有効です.
- CDCAは,脳突起性キサントマトーシス (CTX) に伴う神経疾患の治療に劇的な有効性を示しています.
- CDCAとCAによる治療は,C27胆酸のレベルを低減させることができ,臨床上改善が報告されています.
結論:
- 胆汁酸の代替治療は,特定の先天的な代謝障害の有効な治療法です.
- CDCAおよび/またはCAによる早期診断と介入は,乳幼児の肝疾患と神経学的症状のアウトカムを大幅に改善することができます.
- 特定のペロキシソーマ疾患および他の代謝疾患における胆酸療法の効果を完全に解明するには,さらなる研究が必要である.
関連する概念動画
Inborn Errors of Metabolism
241
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
241
Protein Import into the Peroxisomes
3.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.6K
Phase II Reactions: Miscellaneous Conjugation Reactions
111
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
111
Hepatic Drug Excretion: Enterohepatic Cycling
1.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.7K
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Pedigree Analysis
85.1K
Overview
85.1K


